Filing metadata

Accession number
0001140361-24-041329
Form type
Form 4
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Sep 17, 2024
Reporting period
Sep 13, 2024
Description
Insider transaction

Explore SEC Filings Hub